Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Clinical trial NCT00517829 · COMPLETED

Trial details

NCT number: NCT00517829
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Adenocarcinoma Metastatic

Start date: 2007-07-01
Primary completion: 2012-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.